BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

709 related articles for article (PubMed ID: 15134861)

  • 1. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
    Dumont Y; Chabot JG; Quirion R
    Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions of genes encoding calcitonin/alpha-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone.
    Lerner UH
    J Musculoskelet Neuronal Interact; 2006; 6(1):87-95. PubMed ID: 16675892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptide receptor-C signaling and regulation.
    Anand-Srivastava MB
    Peptides; 2005 Jun; 26(6):1044-59. PubMed ID: 15911072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of G protein-coupled receptors of the adrenomedullin peptide family with accessory receptor-activity-modifying proteins (RAMP).
    Born W; Muff R; Fischer JA
    Microsc Res Tech; 2002 Apr; 57(1):14-22. PubMed ID: 11921352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor pharmacology.
    Young A
    Adv Pharmacol; 2005; 52():47-65. PubMed ID: 16492540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcitonin receptor-stimulating peptide: Its evolutionary and functional relationship with calcitonin/calcitonin gene-related peptide based on gene structure.
    Katafuchi T; Yasue H; Osaki T; Minamino N
    Peptides; 2009 Sep; 30(9):1753-62. PubMed ID: 19540291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of CGRP receptors and peptide pharmacology in human coronary arteries. Characterization with a nonpeptide antagonist.
    Hasbak P; Saetrum Opgaard O; Eskesen K; Schifter S; Arendrup H; Longmore J; Edvinsson L
    J Pharmacol Exp Ther; 2003 Jan; 304(1):326-33. PubMed ID: 12490608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the N-terminal domain of the calcitonin receptor-like receptor in ligand binding.
    Chauhan M; Rajarathnam K; Yallampalli C
    Biochemistry; 2005 Jan; 44(2):782-9. PubMed ID: 15641806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermedin, a novel calcitonin family peptide that exists in teleosts as well as in mammals: a comparison with other calcitonin/intermedin family peptides in vertebrates.
    Chang CL; Roh J; Hsu SY
    Peptides; 2004 Oct; 25(10):1633-42. PubMed ID: 15476930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges.
    Hay DL; Walker CS; Poyner DR
    Endocr Relat Cancer; 2011 Feb; 18(1):C1-14. PubMed ID: 21051558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family.
    Cabrele C; Beck-Sickinger AG
    J Pept Sci; 2000 Mar; 6(3):97-122. PubMed ID: 10759209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms.
    Nikitenko LL; Blucher N; Fox SB; Bicknell R; Smith DM; Rees MC
    J Cell Sci; 2006 Mar; 119(Pt 5):910-22. PubMed ID: 16495482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
    Naot D; Cornish J
    Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the calcitonin receptor, calcitonin receptor-like receptor, and receptor activity modifying proteins during osteoclast differentiation.
    Granholm S; Lundberg P; Lerner UH
    J Cell Biochem; 2008 Jun; 104(3):920-33. PubMed ID: 18384073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiographic evidence for the modulation of in vivo sigma receptor labeling by neuropeptide Y and calcitonin gene-related peptide in the mouse brain.
    Bouchard P; Roman F; Junien JL; Quirion R
    J Pharmacol Exp Ther; 1996 Jan; 276(1):223-30. PubMed ID: 8558435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparisons between the effects of calcitonin receptor-stimulating peptide and intermedin and other peptides in the calcitonin family on bone resorption and osteoclastogenesis.
    Granholm S; Henning P; Lerner UH
    J Cell Biochem; 2011 Nov; 112(11):3300-12. PubMed ID: 21748786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional calcitonin gene-related peptide subtype 2 receptors in porcine coronary arteries are identified as calcitonin gene-related peptide subtype 1 receptors by radioligand binding and reverse transcription-polymerase chain reaction.
    Rorabaugh BR; Scofield MA; Smith DD; Jeffries WB; Abel PW
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1086-94. PubMed ID: 11714898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries.
    De Mey JG; Megens R; Fazzi GE
    J Pharmacol Exp Ther; 2008 Mar; 324(3):930-7. PubMed ID: 18055875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.